Current knowledge on the pathophysiology of schizophrenia

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Progress in Understanding the Neurobiology of Schizophrenia Daphne Holt, MD, PhD Director of Research, Schizophrenia Clinical and Research Program Department.
Interactions Between Reward and Stress Systems
The Addicted Synapse Katie Malanson.
Cellular, Behavioral, and Computational Investigations of Dopamine Modulation of Prefrontal Cortical Networks Jeremy Seamans.
Dopamine Theory of Schizophrenia
Schizophrenia The Unwell Brain. Disturbance in the Neurochemistry  The first discovery in the mid 1950s was that chronic usage of large daily doses of.
1 Brain Circuits Involved in Emotion processing: Subcortical Regions BIOS E 232 Sabina Berretta, MD Harvard Medical School McLean Hospital.
SCHIZOPHRENIA. A bit of history Hideyo Noguchi, 1911: Syphillis (delusions, grandiosity, impulsivity, altered thought structure) is due to bacterium.
 incidence  characteristics  causes?  treatments?
Current knowledge on the pathophysiology of autism BIOS E 232 Sabina Berretta, MD Harvard Medical School McLean Hospital.
Neurodex TM Palliates Pseudobulbar Affect: An Overview of the Pathogenesis of Pseudobulbar Affect and the Pharmacologic Mechanism of Action of Neurodex.
An Integrative Approach to Psychopathology
The Neurobiology of Suicide Student name Date. Background What we’ve studied so far this semester This week: the neurobiological and genetic aspects of.
No Theory of Mind. Weak Central Coherence Executive Dysfunction.
NEURAL CIRCUITRY UNDERLYING IMPAIRED INSIGHT IN SCHIZOPHRENIA: AN FMRI STUDY Mark Benton Department of Psychiatry and Behavioral Neuroscience.
Lesson 3 How Nicotine Interacts with the Brain. A look at the brain Different parts of the brain are involved in different functions, like vision, movement,
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
B 尤思涵. Dopamine and Serotonin Dopamine 4-(2-aminoethyl)benzene-1,2-diol 5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol Serotonin.
Schizophrenia The Unwell Brain. Disturbance in the Neurochemistry  The first discovery in the mid 1950s was that chronic usage of large daily doses of.
[]. [“Cannabis als risicofactor vor psychose: een update”, Kuepper – Van Winkel – Henquet (Tijdschrift voor psychiatrie, 2013)]
Dr.farahzadi.1391 dr.farahzadi Overview of Methamphetamine Pharmacology.
Genetic Variation Influences Glutamate Concentrations in Brains of Patients with Multiple Sclerosis Robby Bonanno.
Schizophrenia Onset can be slow or sudden Typically exists chronically Affects ~1% of population Diagnosis must have at least two symptoms for more that.
Schizophrenia Lecture 23. Mental Illness: Definition n Characteristically Controversial n Deviations from normal l Behavior l Thought Processes l Affect.
1 Chapter 16 Schizophrenia
Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder Jaeseung Jeong, Ph.D Department of Bio.
Chapter 16 Schizophrenia
PSYCHOACTIVE DRUGS Drugs have revolutionized psychiatric treatment since the 1950's. Most psychoactive drugs act stereospecifically on receptors, enzymes,
The Neurobiology of Free Will In National Institute on Drug Abuse
ABERRANT FUNCTIONAL CONNECTIVITY OF DL PFC AND CINGULATE NETWORKS IN PATIENTS WITH MDD DURING WORKING MEMORY PROCESSING By Sharleen Yuan Special Topics-Affective.
Trends in Biomedical Science Making Memory. The following slides are mostly derived from The Brain from Top to Bottom, an Interactive Website about the.
Xavier Fung Miriam Hjertnes.  Thought, mood and anxiety disorder  Neurotransmitter and messaging centre disturbed  Affects ones perception of reality.
By Rahul Kapoor. Based on a study performed by Stephen McGowan MRCPsych Andrew D. LawrenceMRCPsych Tim Sales MRCPsych Digby Quested MRCPsych Paul Grasby.
Pharmacology of central Neurotransmitters Prof. Yieldez.
Neurotransmissions in the Central Nervous System Prof. Alhaider.
Schizophrenia: Biological explanations. Overview Genetic hypothesis Biochemical factors Neuroanatomical factors Prenatal exposure to virus.
Neurochemistry of executive functions
Describe and Evaluate Biological Explanations for Schizophrenia.
The Reward Pathway.
How antipsychotics become anti- ”psychotic” –from dopamine to salience to psychosis Kristoffer Lien.
NETWORK INTERACTIONS IN SZ – THERAPEUTIC IMPLICATIONS
The study of the causes of diseases
Biological explanation of schizophrenia (1)
Contemporary study for schizophrenia
Paper Two Revision: OCD
Evaluation of the dopamine hypothesis (biological explanation)
Network interactions in schizophrenia — therapeutic implications
Dopamine system: neuroanatomy
Metabotropic Neurotransmitter Receptors
The Dopamine Hypothesis Part 2
DOPAMINE HYPOTHESIS.
Catching Up on Schizophrenia
Nature of psychosis and schizophrenia
Dopamine Hypothesis Schizophrenia.
Neurotransmitters.
Neurotransmitters Domina Petric, MD.
The function of neurotransmitters as an explanation of schizophrenia
Dopamine pathways & antipsychotics
Lithium: Mechanism of Action
Neurological Disorders
The Brain on Drugs: From Reward to Addiction
Eleanor H. Simpson, Christoph Kellendonk, Eric Kandel  Neuron 
Neurobiology of Depression
Neurotransmitters.
The role of the PFC in addiction
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders  Daniel J. Foster, P. Jeffrey.
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
Catching Up on Schizophrenia
David A. Lewis, Allison A. Curley, Jill R. Glausier, David W. Volk 
Presentation transcript:

Current knowledge on the pathophysiology of schizophrenia 4/11/2017 Current knowledge on the pathophysiology of schizophrenia Emphasis on factors affecting emotion regulation BIOS E 232 Sabina Berretta, MD Harvard Medical School McLean Hospital

Plan for today’s class • Review Presentations: * Eva Xia, Carlin Aloe, Teresa Morales Gerbaud • Today’s seminar: Current knowledge on the pathophysiology of schizophrenia Emphasis on factors affecting emotion regulation • Journal club presentations and discussion: • Teresa MORALES GERBAUD Benes, F.M., Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology, 2010. 35(1): p. 239-57 • April GARDNER Tamminga, C.A., A.D. Stan, and A.D. Wagner, The hippocampal formation in schizophrenia. Am J Psychiatry, 2010. 167(10): p. 1178-93

Current knowledge on the pathophysiology of schizophrenia

Strong genetic component Supported by family, twin and adoption studies Heritability of schizophrenia has been estimated to be between 65-80% (That is that approximately 65-80% of individual differences in schizophrenia may be attributable to genetic differences)

Some schizophrenia candidate genes and their association with schizophrenia according to chromosomal location, genetic association, biology/animal models, expression alterations, and meta-analysis results Tiwari et al. 2010

Main domains of schizophrenia pathophysiology Neuronal migration • Neurodevelopment Neuronal connectivity Synapse formation Extracellular matrix Dopamine • Neurotransmission Glutamate GABA Serotonin Synaptic proteins • Synaptic physiology Neurotransmitter uptake/synthesis Extracellular matrix • Immune system Cytokines Complements components

Structural brain abnormalities in schizophrenia: Weinberger, NIH • Increased ventricle size • Brain region volume changes Shenton et al., 1992

OPFC ACG DLPFC MD Striatum Amygdala ECx HP 4/11/2017 OPFC Social behavior Representation of reinforcer values ACG Attention Motivation Response selection DLPFC Executive cognitive functions Strategy generation Working memory MD Attention Decoding of stimulus/significance relationship Striatum Reward mechanisms Incentive salience Amygdala Attribution of emotional value Fear/anxiety Social behavior ECx Gating of cortical and subcortical inputs to the HP Memory processing HP Context-related cognitive processing Episodic memory

Neurodevelopment Neuronal migration Interstitial white matter neurons are increased in the superficial white matter. Their expression of NAPDH (Akbarian) and somatostatin (Yang) suggests that they are interneurons. Yang showed a significant negative correlation between SSTmRNA expression in gray matter and NeuN IWMN density. Neuronal nuclear antigen (NeuN)–positive neurons (A) below grey matter (grey matter/white matter border represented by dotted line). In superficial white matter from (B) control and (C) schizophrenia subjects. Yang et al., 2011

Historically, the main neurotransmitter systems have been a major focus in schizophrenia • Dopamine • GABA • Glutamate • Serotonin • Acetylcholine Guillin et al., 2007

Dopamine role in the pathophysiology of schizophrenia • Rabbits treated with reserpine (which blocks neurotransmitter uptake into monoaminergic nerve terminal storage sites) display catalepsy–the maintenance of even abnormal body posture Carlsson, 1957-1959 • Dopamine D2 receptors are targeted by antipsychotics and symptoms of schizophrenia are improved by dopamine antagonists Carlsson, 1963 • Dopamine releasing agents (e.g. amphetamine) exacerbate symptoms of schizophrenia Ellison et al., 1983

The strongest evidence so far is for dopamine dysregulation in the striatum Dopamine D2 receptor availability in striatal subregions measured by PET with carbon 11–labeled raclopride before and during pharmacologically induced dopamine depletion. In the associative striatum, acute dopamine depletion resulted in a larger increase in D2 receptor availability in patients with schizophrenia than in control subjects suggesting higher synaptic dopamine concentration. In schizophrenia, increased D2 receptor transmission in pre commissural dorsal caudate (circle) might affect information processing from the dorsolateral prefrontal cortex Kegeles et al. 2010

The DOPAMINE hypothesis of schizophrenia: 4/11/2017 The DOPAMINE hypothesis of schizophrenia: Version III • Multiple ‘‘hits’’ interact to result in dopamine dysregulation—the final common pathway to psychosis in schizophrenia. Howes and Kapur, 2009 • The locus of dopamine dysregulation moves from being primarily at the D2 receptor level to being at the presynaptic dopaminergic control level • Dopamine dysregulation is linked to ‘‘psychosis’’ rather than schizophrenia From Heinz, SZ Bull 36(3)472 DA is conceptualized as representing a prediction error that indicates the difference between received and predicted reward. In this context, DA mediates the attribution of incentive salience to conditioned cues that predict reward. Increased DA activity in the striatum of SZ may attribute INCENTIVE SALIENCE to otherwise irrelevant stimuli. This mechanisms is postulated to underlie delusion formation • In the striatum, dopamine dysregulation is hypothesized to alter the appraisal of stimuli, perhaps through a process of aberrant salience. Increased dopamine activity in the striatum of SZ may attribute INCENTIVE SALIENCE to otherwise irrelevant stimuli. This mechanism is postulated to underlie delusion formation • In the PFC, chronic low levels of dopamine, and compensatory increase of D1 receptors, may play a role in cognitive impairment

DAT-IR fiber varicosities are decreased in the LN, BN, ABN and CO in schizophrenic subjects

Evidence for excess DA transmission derives from pre- and postsynaptic studies. Excess DA transmission may impair glutamatergic NMDA transmission by a D2-mediated impaired presynaptic release of glutamate and an imbalance of D1/D2 opposing effects onto NMDA transmission Guillin et al., 2007